Exclusive‘Alzheimer’s Gene’ Heightens Alzheimer’s Risk but the Plasmalogen Nutrient Defends Against It—Key to Cure? (Part 1)｜Vital Sig

What does the “Alzheimer’s gene” reveal about the link between Alzheimer’s disease and cholesterol transport in the body?

How is cholesterol transport dependent on the “mystery molecule”—plasmalogen—that can restore brain health?

In 1990, the Human Genome Project began to map the DNA instructions in human cells. This led to discovering the APOE4 gene’s link to higher Alzheimer’s disease risk.

On Vital Signs with Brendon Fallon, Dayan Goodenowe explains this gene’s crucial role in cholesterol regulation. One factor makes it more relevant to understanding and treating Alzheimer’s than the irregular (amyloid and tau) protein build-ups in the brain that have long been the target of Alzheimer’s treatment.

Fifteen years of neuroscientific research led Dr. Goodenowe to discover that plasmalogen—an essential brain nutrient—is much lower than normal in the blood of people with Alzheimer’s.

Is Alzheimer’s being caused by the loss of plasmalogen? What happens when we restore plasmalogen to healthy levels?

For Alzheimer’s: Key to Cure–PART 1, we’ll explore what the Alzheimer’s gene APOE4 signals about the cause of Alzheimer’s and how Dr. Goodenowe’s invention pinpointed low plasmalogen in Alzheimer’s.

For Alzheimer’s: Key to Cure–PART 2 https://ept.ms/AlzheimersAntidote_VS

====================
Vital Signs’ host, guests, and contributors offer general information on improving health and wellness. This is not intended as diagnosis or medical advice. You should consult your medical doctor or holistic doctor before enacting any suggested strategies for health and wellness improvement, including those in relation to preventing or treating specific diseases featured on this program.